Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of AN2690 Solution in Onychomycosis
NCT00679601Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2007
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tavaborole in onychomycosis, sponsored by Pfizer. Started Mar 2007; status: completed.
02
Drugs
tavaborole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT00679601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679601.